Evidence map›Paper›PMID 29372567›Full record

ReviewAlimentary pharmacology & therapeutics2018

Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders.

B P Chumpitazi, G L Kearns, R J Shulman

2 registry-linked trialsOpen access · bronzeAbstract readReview
In one paragraph

Review in Alimentary pharmacology & therapeutics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 67 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed, 1 pooled it
11.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05613153 naenrolling by invitationnot on this mapstarted 2022, after this paper: background citation

Peppermint Oil as an Alternative Treatment for Children With Bladder and Bowel Dysfunction: A Prospective Study

TypeinterventionalSponsorChildren's Hospital of Orange CountyRan2022 to 2026Enrolled30ConditionsBladder and Bowel DysfunctionArmsPeppermint Oil
NCT06268964 phase1 / phase2recruitingnot on this mapstarted 2024, after this paper: background citation

Comparative Effect of Trimebutine and Probiotics on Functional Abdominal Pain Disorders (FAPD) in Children: Randomized Clinical Trial (RCT)

TypeinterventionalSponsorUniversidad de ColimaRan2024 to 2025Enrolled82ConditionsFunctional Abdominal Pain Syndrome, Functional Gastrointestinal Disorders, Irritable Bowel Syndrome Variant of ChildhoodArmsTrimebutine, Lactobacillus rhamnosus, Placebo
3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 1 synthesis or guideline pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Diagnosis and treatment of irritable bowel syndrome with diarrhea: Key clinical considerations.Journal of the American Association of Nurse Practitioners · 2026
    Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Expert Opinion on the Efficacy and Safety of Antispasmodics with a Focus on Irritable Bowel Syndrome.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

B P ChumpitaziDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.ORCID 0000-0002-0829-0036
G L KearnsArkansas Children's Research Institute, Little Rock, AR, USA.
R J ShulmanDepartment of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine · USArkansas Children's Hospital · US

Funding

Tissue Analysis & Molecular Imaging CoreP30DK056338 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI Geoffrey A Preidis · 2001 to 2026
$28.3M
PATHWAYS TO NEW BIOMARKERS IN RECURRENT ABDOMINAL PAIN IN CHILDRENR01NR013497 · NINR · BAYLOR COLLEGE OF MEDICINE · PI SAVIDGE, TOR C. · 2012 to 2024
$4.7M
Intestinal Microbiome Fructan Metabolism and Symptom Generation in Childhood IBSK23DK101688 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI CHUMPITAZI, BRUNO PEDRO · 2014 to 2018
$879k
Peppermint Oil Pharmacokinetics/Dynamics and Novel Biological Signatures in Children with Functional Abdominal PainR21AT009101 · NCCIH · BAYLOR COLLEGE OF MEDICINE · PI SHULMAN, ROBERT J · 2016 to 2017
$436k
NCCIH NIH HHS R21 AT009101NIDDK NIH HHS K23 DK101688NIDDK NIH HHS P30 DK056338NINR NIH HHS R01 NR013497
6 · The paper itself

Abstract

backgroundPeppermint oil has been used for centuries as a treatment for gastrointestinal ailments. It has been shown to have several effects on gastrointestinal physiology relevant to clinical care and management.

aimTo review the literature on peppermint oil regarding its metabolism, effects on gastrointestinal physiology, clinical use and efficacy, and safety.

methodsWe performed a PubMed literature search using the following terms individually or in combination: peppermint, peppermint oil, pharmacokinetics, menthol, oesophagus, stomach, small intestine, gallbladder, colon, transit, dyspepsia, nausea, abdominal pain, and irritable bowel syndrome. Full manuscripts evaluating peppermint oil that were published through 15 July 2017 were reviewed. When evaluating therapeutic indications, only randomised clinical trials were included. References from selected manuscripts were used if relevant.

resultsIt appears that peppermint oil may have several mechanisms of action including: smooth muscle relaxation (via calcium channel blockade or direct enteric nervous system effects); visceral sensitivity modulation (via transient receptor potential cation channels); anti-microbial effects; anti-inflammatory activity; modulation of psychosocial distress. Peppermint oil has been found to affect oesophageal, gastric, small bowel, gall-bladder, and colonic physiology. It has been used to facilitate completion of colonoscopy and endoscopic retrograde cholangiopancreatography. Placebo controlled studies support its use in irritable bowel syndrome, functional dyspepsia, childhood functional abdominal pain, and post-operative nausea. Few adverse effects have been reported in peppermint oil trials.

conclusionPeppermint oil is a natural product which affects physiology throughout the gastrointestinal tract, has been used successfully for several clinical disorders, and appears to have a good safety profile.

Indexed as

Abdominal PainChildDyspepsiaGastrointestinal DiseasesGastrointestinal TractHumansIrritable Bowel SyndromeMentha piperitaPlant OilsTreatment Outcomepeppermint oilPlant Oils

Identifiers

PMID29372567
PMCPMC5814329
OpenAlexW2791635672

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.